What is BofA Securities's price target for CDLX?

BofA Securities's latest stated price target for Cardlytics Inc. (CDLX) is $3.50, from its action on Aug 15, 2024.

What is BofA Securities's rating on CDLX?

BofA Securities rates CDLX Underperform, a bearish rating, as of Aug 15, 2024.

When did BofA Securities last change its view on CDLX?

On Aug 15, 2024, BofA Securities downgrades to Underperform from Neutral, price target $4 to $3.50.

BofA Securities CDLX price target and rating history

BofA Securities rates Cardlytics Inc. (CDLX) Underperform with a $3.50 price target, as of its latest action on Aug 15, 2024. It has published 3 rating actions on CDLX since July 2022, including 0 upgrades and 2 downgrades.

Current rating: Underperform
Price target: $3.50
Median target, all firms: Too few
Actions on CDLX: 3

BofA Securities price target on CDLX

BofA Securities price target on CDLX, each point a stated target, July 2022 to August 2024.

Every BofA Securities rating on CDLX

Aug 15, 2024
DowngradeBofA Securities downgrades to Underperform from Neutral, price target $4 to $3.50
Jun 20, 2024
ResumeBofA Securities resumes coverage at Neutral, price target $11
Jul 13, 2022
DowngradeBofA Securities downgrades to Underperform from Neutral, price target $14

Questions about BofA Securities and CDLX

What is BofA Securities's price target for CDLX?: BofA Securities's latest stated price target for Cardlytics Inc. (CDLX) is $3.50, from its action on Aug 15, 2024.
What is BofA Securities's rating on CDLX?: BofA Securities rates CDLX Underperform, a bearish rating, as of Aug 15, 2024.
When did BofA Securities last change its view on CDLX?: On Aug 15, 2024, BofA Securities downgrades to Underperform from Neutral, price target $4 to $3.50.

More CDLX rating histories

All BofA Securities ratings CDLX news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.